FDA ANDA · ANDA219628
ATROPINE SULFATE
Sponsor: SENTISS PHARMA
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA219628
TYPE
ANDA
ORIGINAL APPROVAL
2026-10-16
LATEST ACTION
2026-10-16
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
ATROPINE SULFATEPrescription
ATROPINE SULFATE 1% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2026-10-16UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →